Patents by Inventor Jason A. Hackney

Jason A. Hackney has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240417461
    Abstract: The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: February 16, 2024
    Publication date: December 19, 2024
    Inventors: Hilary CLARK, Dan EATON, Lino GONZALEZ, JR., Jane GROGAN, Jason A. HACKNEY, Kristin BOWLES, Xin YU
  • Publication number: 20230098521
    Abstract: The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: June 15, 2022
    Publication date: March 30, 2023
    Inventors: Hilary CLARK, Dan EATON, Lino GONZALEZ, Jr., Jane GROGAN, Jason A. HACKNEY, Kristin BOWLES, Xin YU
  • Patent number: 11390678
    Abstract: The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: July 19, 2022
    Assignee: Genentech, Inc.
    Inventors: Hilary Clark, Dan Eaton, Lino Gonzalez, Jr., Jane Grogan, Jason A. Hackney, Kristin Bowles, Xin Yu
  • Publication number: 20220186314
    Abstract: Biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies, and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease.
    Type: Application
    Filed: January 20, 2022
    Publication date: June 16, 2022
    Applicant: GENENTECH, INC.
    Inventors: Jason A. Hackney, Mary Keir, Gaik Wei Tew
  • Patent number: 11261493
    Abstract: Biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies, and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: March 1, 2022
    Assignee: GENENTECH, INC.
    Inventors: Jason A. Hackney, Mary Keir, Gaik Wei Tew
  • Publication number: 20200325538
    Abstract: Biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies, and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease.
    Type: Application
    Filed: April 10, 2020
    Publication date: October 15, 2020
    Applicant: GENENTECH, INC.
    Inventors: Jason A. Hackney, Mary Keir, Gaik Wei Tew
  • Publication number: 20200317773
    Abstract: The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: August 9, 2019
    Publication date: October 8, 2020
    Inventors: Hilary CLARK, Dan EATON, Lino GONZALEZ, Jr., Jane GROGAN, Jason A. HACKNEY, Kristin BOWLES, Xin YU
  • Patent number: 10669587
    Abstract: Biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies, and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease.
    Type: Grant
    Filed: March 7, 2019
    Date of Patent: June 2, 2020
    Assignee: GENENTECH, INC.
    Inventors: Jason A. Hackney, Mary Keir, Gaik Wei Tew
  • Publication number: 20190256913
    Abstract: Biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies, and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease.
    Type: Application
    Filed: March 7, 2019
    Publication date: August 22, 2019
    Applicant: GENENTECH, INC.
    Inventors: Jason A. Hackney, Mary Keir, Gaik Wei Tew
  • Patent number: 10377823
    Abstract: The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Grant
    Filed: August 8, 2016
    Date of Patent: August 13, 2019
    Assignee: Genentech, Inc.
    Inventors: Hilary Clark, Dan Eaton, Lino Gonzalez, Jr., Jane Grogan, Jason A. Hackney, Kristin Bowles, Xin Yu
  • Patent number: 10273542
    Abstract: Biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies, and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease.
    Type: Grant
    Filed: September 21, 2016
    Date of Patent: April 30, 2019
    Assignee: GENENTECH, INC.
    Inventors: Jason A. Hackney, Mary Keir, Gaik Wei Tew
  • Publication number: 20170233809
    Abstract: Biomarkers predictive of responsiveness to integrin beta7 antagonists, including anti-beta7 integrin subunit antibodies, and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease are provided. Also provided are methods of using such predictive biomarkers for the treatment of inflammatory bowel diseases including ulcerative colitis and Crohn's disease.
    Type: Application
    Filed: September 21, 2016
    Publication date: August 17, 2017
    Applicant: Genentech, Inc.
    Inventors: Jason A. Hackney, Mary Keir, Gaik Wei Tew
  • Publication number: 20170145093
    Abstract: The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: August 8, 2016
    Publication date: May 25, 2017
    Inventors: Hilary CLARK, Dan EATON, Lino GONZALEZ, JR., Jane GROGAN, Jason A. HACKNEY, Kristin BOWLES, Xin YU
  • Publication number: 20160178644
    Abstract: Biomarkers for diagnosing inflammatory bowel disease, including Crohn's disease, including fibrotic or fibrostenotic Crohn's disease, and ulcerative colitis and methods of using such biomarkers are provided. In addition, methods of treating gastrointestinal inflammatory disorders such as inflammatory bowel diseases including ulcerative colitis and Crohn's disease, including fibrotic or fibrostenotic Crohn's disease, are provided.
    Type: Application
    Filed: November 17, 2015
    Publication date: June 23, 2016
    Applicant: GENENTECH, INC.
    Inventors: Jason A. Hackney, Mary Keir, Lilyan Yi Tian Wright
  • Publication number: 20130251720
    Abstract: The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: October 9, 2012
    Publication date: September 26, 2013
    Applicant: GENENTECH, INC.
    Inventors: HILARY CLARK, DAN EATON, LINO GONZALEZ, JR., JANE GROGAN, JASON A. HACKNEY, KRISTIN HARDEN, XIN YU
  • Publication number: 20100297127
    Abstract: This invention relates to methods of treating the autoimmune disorder lupus with IL-27 antagonists, as well as articles of manufacture comprising IL-27 antagonists. The invention also relates to methods and kits for identifying patients that are likely to respond to an IL-27 antagonist treatment.
    Type: Application
    Filed: April 8, 2010
    Publication date: November 25, 2010
    Inventors: Nico P. GHILARDI, Marcel L. BATTEN, Jason A. HACKNEY
  • Publication number: 20090258013
    Abstract: The present invention relates to compositions and methods of using those compositions for the diagnosis and treatment of immune related diseases.
    Type: Application
    Filed: April 8, 2009
    Publication date: October 15, 2009
    Applicant: Genentech, Inc.
    Inventors: Hilary Clark, Dan Eaton, Lino Gonzalez, JR., Jane Grogan, Jason A. Hackney, Kristin Harden, Xin YU